blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1414408

EP1414408 - COMPOSITION COMPRISING PAROXETINE AND A PHARMACEUTICALLY ACCEPTABLE GLYCYRRHIZINATE SALT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.02.2007
Database last updated on 27.07.2024
Most recent event   Tooltip12.12.2008Lapse of the patent in a contracting state
New state(s): CY		published on 14.01.2009  [2009/03]
Applicant(s)For all designated states
SMITHKLINE BEECHAM PLC
980 Great West Road Brentford
Middlesex TW8 9GS / GB
[2006/13]
Former [2004/19]For all designated states
SMITHKLINE BEECHAM PLC
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Inventor(s)01 / BARGES CAUSERET, Nathalie C. M.
Lab. glaxoSmithk.
ZI du Terras -BP 2 53101 Mayenne, Cedex / FR
02 / MARZOLINI, Nicola L. A. GlaxoSmithKline
New Frontiers Science Park South Third Avenue
Harlow, Essex CM19 5AW / GB
03 / MENEAUD, Padma GlaxoSmithKline
New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
 [2004/19]
Representative(s)Knight, Lucie Viktoria
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2004/19]Knight, Lucie Viktoria
GlaxoSmithKline, CIP, CN925.1.980, Great West Road
Brentford, Middlesex TW8 0GS / GB
Application number, filing date02767353.209.08.2002
[2004/19]
WO2002EP08925
Priority number, dateGB2001001947009.08.2001         Original published format: GB 0119470
GB2001001946909.08.2001         Original published format: GB 0119469
GB2001001946709.08.2001         Original published format: GB 0119467
GB2001001946809.08.2001         Original published format: GB 0119468
[2004/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03013470
Date:20.02.2003
Language:EN
[2003/08]
Type: A1 Application with search report 
No.:EP1414408
Date:06.05.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 20.02.2003 takes the place of the publication of the European patent application.
[2004/19]
Type: B1 Patent specification 
No.:EP1414408
Date:29.03.2006
Language:EN
[2006/13]
Search report(s)International search report - published on:EP20.02.2003
ClassificationIPC:A61K9/00, A61K47/26, A61K31/443
[2004/19]
CPC:
A61K9/0056 (EP,US); A61K47/26 (EP,US); A61P25/22 (EP);
A61P25/24 (EP); A61P43/00 (EP); A61K9/2018 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/19]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ZUSAMMENSETZUNG ENTHALTEND PAROXETIN UND EIN PHARMAZEUTISCH VERTRÄGLICHES SALZ VON GLYCYRRHIZINSÄURE[2005/35]
English:COMPOSITION COMPRISING PAROXETINE AND A PHARMACEUTICALLY ACCEPTABLE GLYCYRRHIZINATE SALT[2004/19]
French:COMPOSITION COMPRENANT DE LA PAROXETINE ET UN SEL DE GLYCYRRHIZINATE PHARMACEUTIQUEMENT ACCEPTABLE[2004/19]
Former [2004/19]ZUSAMMENSETZUNG ENTHALTEND PAROXETINE UND EIN PHARMAZEUTISCH VERTRÄGLICHES SALZ VON GLYCYRRHIZINICSÄURE
Entry into regional phase02.02.2004National basic fee paid 
02.02.2004Designation fee(s) paid 
02.02.2004Examination fee paid 
Examination procedure17.02.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
02.02.2004Examination requested  [2004/19]
22.12.2004Despatch of a communication from the examining division (Time limit: M04)
07.04.2005Reply to a communication from the examining division
10.10.2005Communication of intention to grant the patent
02.12.2005Fee for grant paid
02.12.2005Fee for publishing/printing paid
Opposition(s)02.01.2007No opposition filed within time limit [2007/11]
Fees paidRenewal fee
06.08.2004Renewal fee patent year 03
08.08.2005Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT29.03.2006
CH29.03.2006
CY29.03.2006
CZ29.03.2006
EE29.03.2006
FI29.03.2006
LI29.03.2006
NL29.03.2006
SK29.03.2006
TR29.03.2006
BG29.06.2006
DK29.06.2006
SE29.06.2006
GR30.06.2006
IE09.08.2006
LU09.08.2006
PT29.08.2006
MC31.08.2006
[2009/03]
Former [2008/37]AT29.03.2006
CH29.03.2006
CZ29.03.2006
EE29.03.2006
FI29.03.2006
LI29.03.2006
NL29.03.2006
SK29.03.2006
TR29.03.2006
BG29.06.2006
DK29.06.2006
SE29.06.2006
GR30.06.2006
IE09.08.2006
LU09.08.2006
PT29.08.2006
MC31.08.2006
Former [2008/28]AT29.03.2006
CH29.03.2006
CZ29.03.2006
EE29.03.2006
FI29.03.2006
LI29.03.2006
NL29.03.2006
SK29.03.2006
BG29.06.2006
DK29.06.2006
SE29.06.2006
GR30.06.2006
IE09.08.2006
PT29.08.2006
MC31.08.2006
Former [2008/21]AT29.03.2006
CH29.03.2006
CZ29.03.2006
LI29.03.2006
NL29.03.2006
SK29.03.2006
BG29.06.2006
DK29.06.2006
SE29.06.2006
GR30.06.2006
IE09.08.2006
PT29.08.2006
MC31.08.2006
Former [2007/45]AT29.03.2006
CH29.03.2006
LI29.03.2006
NL29.03.2006
SK29.03.2006
BG29.06.2006
DK29.06.2006
SE29.06.2006
IE09.08.2006
PT29.08.2006
MC31.08.2006
Former [2007/42]AT29.03.2006
CH29.03.2006
IT29.03.2006
LI29.03.2006
NL29.03.2006
SK29.03.2006
BG29.06.2006
DK29.06.2006
SE29.06.2006
IE09.08.2006
PT29.08.2006
MC31.08.2006
Former [2007/39]AT29.03.2006
CH29.03.2006
IT29.03.2006
LI29.03.2006
NL29.03.2006
SK29.03.2006
BG29.06.2006
DK29.06.2006
SE29.06.2006
PT29.08.2006
MC31.08.2006
Former [2007/19]AT29.03.2006
CH29.03.2006
LI29.03.2006
NL29.03.2006
SK29.03.2006
BG29.06.2006
DK29.06.2006
SE29.06.2006
PT29.08.2006
MC31.08.2006
Former [2007/11]AT29.03.2006
CH29.03.2006
LI29.03.2006
SK29.03.2006
BG29.06.2006
DK29.06.2006
SE29.06.2006
PT29.08.2006
Former [2007/03]AT29.03.2006
CH29.03.2006
LI29.03.2006
SK29.03.2006
BG29.06.2006
SE29.06.2006
Former [2006/48]AT29.03.2006
BG29.06.2006
SE29.06.2006
Former [2006/46]AT29.03.2006
SE29.06.2006
Former [2006/43]AT29.03.2006
Cited inInternational search[A]US4721723  (BARNES ROGER D [GB], et al) [A] 1-11* claims 1-6 *;
 [Y]EP0433004  (WARNER LAMBERT CO [US]) [Y] 1-11 * page 4, line 15 - line 17 * * page 5, line 40 *;
 [Y]US5811436  (LEONARD GRAHAM STANLEY [GB], et al) [Y] 1-11 * column 1, line 35 - line 39 *;
 [Y]WO0112161  (NOVARTIS CONSUMER HEALTH SA [CH], et al) [Y] 1-11 * page 12, paragraph 4 *;
 [E]WO02074238  (LAVIPHARM LAB INC [US]) [E] 1-11 * page 5, paragraph 19 * * page 10, paragraph 39 * * page 15, line 14 - line 20 *;
 [Y]  - J. FALBE, M. REGITZ, Römpp Lexicon, 10. Auflage, Band 2 (Cm-G), STUTTGART, THIEME, (1997), XP002220421 [Y] 1-11 * page 1576, column 1, paragraph GLYCYRRHIZIN *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.